Recruiting
Phase 1
Phase 2

Inotuzumab Ozogamicin

Sponsor:

Leland Metheny

Code:

NCT03104491

Conditions

Acute Lymphocytic Leukemia

Eligibility Criteria

Sex: All

Age: 16 - 70+

Healthy Volunteers: Not accepted

Interventions

Inotuzumab Ozogamicin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information